Considerations on Discontinuing Natalizumab for the Treatment of Multiple Sclerosis

Xavier Montalban; Joseph R. Berger; Diego Centonze; Giancarlo Comi; Christian Confavreux; Gary Cutter; Gavin Giovannoni; Ralf Gold; Hans-Peter Hartung; Fred Lublin; Augusto Miravalle; Paul O'Connor; Tomas Olsson; Chris H. Polman; Olaf Stuve; Jerry S. Wolinsky; Tjalf Ziemssen

doi:10.1002/ana.22083

Considerations on Discontinuing Natalizumab for the Treatment of Multiple Sclerosis

Xavier Montalban, Joseph R. Berger, Diego Centonze, Giancarlo Comi, Christian Confavreux, Gary Cutter, Gavin Giovannoni, Ralf Gold, Hans-Peter Hartung, Fred Lublin, Augusto Miravalle, Paul O'Connor, Tomas Olsson, Chris H. Polman, Olaf Stuve, Jerry S. Wolinsky, Tjalf Ziemssen

Departament de Medicina

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

39 Citacions (Web of Science)

Idioma original	Anglès
Pàgines (de-a)	409-411
Nombre de pàgines	3
Revista	Annals of Neurology
Volum	68
Número	3
DOIs	https://doi.org/10.1002/ana.22083
Estat de la publicació	Publicada - de set. 2010

Accés al document

10.1002/ana.22083

Altres arxius i enllaços

Mostra el registre a Web of Science

Com citar-ho

Montalban, X., Berger, J. R., Centonze, D., Comi, G., Confavreux, C., Cutter, G., Giovannoni, G., Gold, R., Hartung, H.-P., Lublin, F., Miravalle, A., O'Connor, P., Olsson, T., Polman, C. H., Stuve, O., Wolinsky, J. S., & Ziemssen, T. (2010). Considerations on Discontinuing Natalizumab for the Treatment of Multiple Sclerosis. Annals of Neurology, 68(3), 409-411. https://doi.org/10.1002/ana.22083

@article{c7f5a9844fc3435d9e9a38416a9ba552,

title = "Considerations on Discontinuing Natalizumab for the Treatment of Multiple Sclerosis",

keywords = "Immune reconstitution syndrome, Therapy, Cessation, Relapses",

author = "Xavier Montalban and Berger, {Joseph R.} and Diego Centonze and Giancarlo Comi and Christian Confavreux and Gary Cutter and Gavin Giovannoni and Ralf Gold and Hans-Peter Hartung and Fred Lublin and Augusto Miravalle and Paul O'Connor and Tomas Olsson and Polman, {Chris H.} and Olaf Stuve and Wolinsky, {Jerry S.} and Tjalf Ziemssen",

year = "2010",

month = sep,

doi = "10.1002/ana.22083",

language = "English",

volume = "68",

pages = "409--411",

journal = "Annals of Neurology",

issn = "0364-5134",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

Montalban, X, Berger, JR, Centonze, D, Comi, G, Confavreux, C, Cutter, G, Giovannoni, G, Gold, R, Hartung, H-P, Lublin, F, Miravalle, A, O'Connor, P, Olsson, T, Polman, CH, Stuve, O, Wolinsky, JS & Ziemssen, T 2010, 'Considerations on Discontinuing Natalizumab for the Treatment of Multiple Sclerosis', Annals of Neurology, vol. 68, núm. 3, pàg. 409-411. https://doi.org/10.1002/ana.22083

TY - JOUR

T1 - Considerations on Discontinuing Natalizumab for the Treatment of Multiple Sclerosis

AU - Montalban, Xavier

AU - Berger, Joseph R.

AU - Centonze, Diego

AU - Comi, Giancarlo

AU - Confavreux, Christian

AU - Cutter, Gary

AU - Giovannoni, Gavin

AU - Gold, Ralf

AU - Hartung, Hans-Peter

AU - Lublin, Fred

AU - Miravalle, Augusto

AU - O'Connor, Paul

AU - Olsson, Tomas

AU - Polman, Chris H.

AU - Stuve, Olaf

AU - Wolinsky, Jerry S.

AU - Ziemssen, Tjalf

PY - 2010/9

Y1 - 2010/9

KW - Immune reconstitution syndrome

KW - Therapy

KW - Cessation

KW - Relapses

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uab_pure&SrcAuth=WosAPI&KeyUT=WOS:000281421800023&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1002/ana.22083

DO - 10.1002/ana.22083

M3 - Article

C2 - 20818795

SN - 0364-5134

VL - 68

SP - 409

EP - 411

JO - Annals of Neurology

JF - Annals of Neurology

IS - 3

ER -